Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase 4 2Phase 3 2Phase 1/2 1Phase 1 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1

Conditions

Vomiting 3Neoplasms 3Sarcoma 1Nausea 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1

Interventions

Dexamethasone 9Calcium Dobesilate 8Aprepitant 7Ondansetron 6dexamethasone acetate 5Therapeutics 5Palonosetron 4Granisetron 4Doxorubicin 4fosaprepitant 3dexamethasone 21-phosphate 3Vincristine 3Psychiatric Rehabilitation 3Cyclophosphamide 3auricularum 2Yoga 2Surveys and Questionnaires 2Standard of Care 2Metoclopramide 2Mesna 2Lorazepam 2Ifosfamide 2Diphenhydramine 2Control Groups 2Acupuncture Therapy 2Acupressure 2salicylhydroxamic acid 1phenazine 1peppermint oil 1dolasetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Vomiting × fosaprepitant × Clear all
NCT05230654 2022-02-09

Efficacy and Safety of Fosaprepitant in Preventing Chemotherapy-induced Vomiting in Children Treated With Medium and High Emetic Chemotherapeutic Drugs

Shanghai Children's Medical Center

Phase NA Unknown
120 enrolled

Vomiting

NCT04873284 2021-05-10

Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner Patients

Shanghai Children's Medical Center

Phase NA Unknown
120 enrolled

Neoplasms, Vomiting

NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

M.D. Anderson Cancer Center

Phase NA Completed
47 enrolled 6 charts
Sarcoma

Nausea, Neoplasms, Sarcoma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡